Biotechnology
| Reports available on Piribo |
Publication Date |
Price |
|
Gene Therapy
|
April 2010 |
£3000 |
|
Nanobiotechnology
|
April 2010 |
£3000 |
|
DNA sequencing
|
April 2010 |
£1200 |
|
Biomarkers
|
April 2010 |
£3000 |
Biopharmaceuticals
A Global Market Overview
|
April 2010 |
£3115 |
Global Drug Eluting Balloons (DEB)
Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
|
April 2010 |
£2330 |
Proteomics
|
April 2010 |
£3000 |
Cytogenetics
|
April 2010 |
£1465 |
Booming Biotech Market in India
|
April 2010 |
£935 |
US Stem Cell Market Analysis
|
April 2010 |
£535 |
|
RNAi
|
April 2010 |
£2330 |
Biosimilars: A Growing Market
An overview of developments, companies & commercial opportunities
|
March 2010 |
£1495 |
Adult Stem Cells and iPSCs 2010 Market Report
|
March 2010 |
£1625 |
Building Biotech Technology Transfer Opportunities
Sponsor and developer strategies for success
|
February 2010 |
£2555 |
|
Nanobiotechnology
|
February 2010 |
£2965 |
|
Fermenters
|
February 2010 |
£2300 |
|
Prebiotics
|
February 2010 |
£2300 |
Stem Cell Research
Market Trends, Investment Trends and Pipeline Analysis
|
February 2010 |
£2330 |
Ribonucleic Acid (RNA) Therapeutics
Strong Potential to Address Unmet Needs in Pharma
|
February 2010 |
£2330 |
|
Epigenetics
|
February 2010 |
£3000 |
Top 10 Biotechnology Companies
SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
|
February 2010 |
£2330 |
Small and Medium Biopharmaceutical Enterprises in North America and Europe
Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
|
February 2010 |
£2330 |
|
Biomarkers, Tests and Trends for Drug R&D
|
February 2010 |
£1460 |
|
DNA Sequencing
Technologies, Markets and Companies |
January 2010 |
£1115 |
|
Cell Therapy
Technologies, Markets and Companies |
January 2010 |
£3090 |
|
Chinese Markets for Monoclonal Antibody |
January 2010 |
£2470 |
Targeting Cancer Stem Cells
Emerging Therapeutic, Therapeutic Strategies and Pipeline Developments
(2010) |
January 2010 |
£1599 |
Cell Screening Tools, Stem Cells and Related Analytical Products for
Drug/Cell Therapy R&D
Equipment, Tools, Technologies, Opportunities & WW Market Outlook |
January 2010 |
£1015 |
Nanobiotechnology
Applications, Markets and Companies |
January 2010 |
£2780 |
Cytogenetics
Technologies, Markets and Companies |
January 2010 |
£1360 |
Antiviral Therapeutics
Technologies, Markets and Companies |
January 2010 |
£1980 |
Biomarkers
Technologies, Markets and Companies |
January 2010 |
£2780 |
Gene Therapy
Technologies, Markets and Companies |
January 2010 |
£2780 |
Drug Delivery to Central Nervous System Diseases
Technologies, Markets and Companies |
January 2010 |
£1730 |
Proteomics
Technologies, Markets and Companies |
January 2010 |
£2780 |
RNAi
Technologies, Markets and Companies |
January 2010 |
£2165 |
Transdermal Drug Delivery
Technologies, Markets and Companies |
January 2010 |
£1730 |
Pain Therapeutics
Drugs, Markets and Companies |
January 2010 |
£2165 |
Proteomics
Technologies, Markets and Companies |
January 2010 |
£2780 |
Regenerative Medicine
Global Market Trends |
November 2009 |
£1850 |
Biotechnology Instrumentation
International Market Trends |
November 2009 |
£1850 |
The Future of Biosimilars
Market Forecasts to 2015 |
December 2009 |
£2165 |
Top 10 Biotech Companies. Market Outlook, 2008-2023
The global biotech drug market was worth over $75bn in 2007, with
double-figure growth noticeably higher that that of the overall
pharmaceutical market. This report will help you to understand those
developments and their significance. That report provides valuable
commercial information on this exciting industry that no healthcare
company should ignore.
read more ...
Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related
assays or tests used in drug R&D. The study reviews this dynamic market
by looking at drug research and development spending trends, M&As,
alliances, major diseases, applications, tools, technologies, products
and services. This report suggests the future direction of the market
for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or
tests used in the next-generation of drug R&D. This study sizes the
world market and growth rate of biomarkers and assays for drug R&D
spending to 2012.
Read more ...
RNA interference
markets
Since its discovery, the naturally occurring RNA (ribonucleic acid)
interference effect has been acclaimed as the most exciting technical
breakthrough in biological research in the last decade. Some industry
analysts predict that RNA interference (RNAi) may even surpass PCR as a
top technology. Read more
...
Report: Molecular Diagnostics.
Technologies, Markets and Companies
This best-selling report describes and evaluates the molecular
diagnostics technologies that will play an important role in practice of
medicine, public health, pharmaceutical industry, forensics and
biological warfare in the 21st century. Aimed at chief executives and
chief development officers, it is the most comprehensive and up-to-date
one-stop source of information on technical and commercial aspects of
molecular diagnostics. It includes profiles of 250 companies
more ...
Drug Delivery in Cancer Technologies, Markets and Companies
|
May 2009 |
£1990 |
Nitric Oxide: Therapeutics, Markets and Companies
|
May 2009 |
£1855 |
RNAi Technologies, Markets and Companies
|
May 2009 |
£1990 |
Cell Therapy Technologies, Markets and Companies
|
May 2009 |
£2985 |
Cell Culture: The World Market for Media, Sera and Reagents. 2nd Edition
|
May 2009 |
£2650 |
DNA Sequencing. Technologies,Markets and Companies
|
May 2009 |
£665 |
A Quick Guide to Biotechnology and Healthcare in the Middle East
|
April 2009 |
£190 |
6th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
|
April 2009 |
£1120 |
Companion Biomarkers in Drug Development
|
April 2009 |
£2255 |
Biotechnology in the US. IBISWorld Industry Report
|
March 2009 |
£430 |
Bioinformatics Markets. Strategies, Business Models and Trends for the Future
|
March 2009 |
£2255 |
The Future of Biobanks. Regulation, ethics, investment and the humanization of drug discovery
|
March 2009 |
£2025 |
The Future of Biobanks. Regulation, ethics, investment and the humanization of drug discovery
|
March 2009 |
£2025 |
More reports
Click on a title to see a summary of the report on Piribo
To top
|
|
|